Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines
W Ageno, AS Gallus, A Wittkowsky, M Crowther… - Chest, 2012 - Elsevier
Background The objective of this article is to summarize the published literature concerning
the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently …
the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently …
American Heart Association/American College of Cardiology foundation guide to warfarin therapy
rin. 25, 26 Inhibition of S-warfarin metabolism is more important clinically because this
isomer is 5 times more potent than the R-isomer as a vitamin K antagonist. 25, 26 …
isomer is 5 times more potent than the R-isomer as a vitamin K antagonist. 25, 26 …
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines
J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - Chest, 2008 - Elsevier
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians Evidence-Based …
antagonists (VKAs) is part of the American College of Chest Physicians Evidence-Based …
Systematic overview of warfarin and its drug and food interactions
AM Holbrook, JA Pereira, R Labiris… - Archives of internal …, 2005 - jamanetwork.com
Background Warfarin is a highly efficacious oral anticoagulant, but its use is limited by a well-
founded fear of bleeding. Drug and food interactions are frequently cited as causes of …
founded fear of bleeding. Drug and food interactions are frequently cited as causes of …
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range
J Hirsh, JE Dalen, DR Anderson, L Poller, H Bussey… - Chest, 2001 - journal.chestnet.org
Abbreviations: AFASAK Atrial Fibrillation, Aspirin, Anticoagulation; AMI acute myocardial
infarction; AF atrial fibrillation; CARS Coumadin Aspirin Reinfarction Study; CI confidence …
infarction; AF atrial fibrillation; CARS Coumadin Aspirin Reinfarction Study; CI confidence …
The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
J Ansell, J Hirsh, L Poller, H Bussey, A Jacobson… - Chest, 2004 - Elsevier
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the Seventh American College of Chest Physicians Conference …
antagonists (VKAs) is part of the Seventh American College of Chest Physicians Conference …
[图书][B] Koda-Kimble and Young's applied therapeutics: the clinical use of drugs
MA Koda-Kimble - 2012 - books.google.com
This widely used text uses a case-based approach to help students master the fundamentals
of drug therapeutics. Students will learn the basics of common diseases and disorders and …
of drug therapeutics. Students will learn the basics of common diseases and disorders and …
Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines
S Schulman, RJ Beyth, C Kearon, MN Levine - Chest, 2008 - Elsevier
This article about hemorrhagic complications of anticoagulant and thrombolytic treatment is
part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians …
part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians …
Osteoarthritis: new insights. Part 2: treatment approaches
DT Felson, RC Lawrence, MC Hochberg… - Annals of internal …, 2000 - acpjournals.org
Osteoarthritis is the most common form of arthritis, affecting millions of people in the United
States. It is a complex disease whose etiology bridges biomechanics and biochemistry …
States. It is a complex disease whose etiology bridges biomechanics and biochemistry …
Osteoarthritis: an overview of the disease and its treatment strategies
P Sarzi-Puttini, MA Cimmino, R Scarpa… - Seminars in arthritis and …, 2005 - Elsevier
Osteoarthritis (OA) is currently defined by the American College of Rheumatology as a
“heterogeneous group of conditions that leads to joint symptoms and signs which are …
“heterogeneous group of conditions that leads to joint symptoms and signs which are …